Stock BIOSANTE PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Biosante Pharmaceuticals Inc Nasdaq

Equities

US09065V3024

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Biosante Pharmaceuticals Inc
07-02 ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets MT
07-02 ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets
MT
ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
AQ
ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
CI
ANI Pharmaceuticals, Inc.(NasdaqGM:ANIP) dropped from Russell 3000E Growth Index
CI
ANI Pharmaceuticals, Inc.(NasdaqGM:ANIP) dropped from Russell 3000E Index
CI
ANI Pharmaceuticals, Inc.(NasdaqGM:ANIP) dropped from Russell Microcap Index
CI
ANI Pharmaceuticals, Inc.(NasdaqGM:ANIP) dropped from Russell Microcap Growth Index
CI
ANI Pharmaceuticals, Inc.(NasdaqGM:ANIP) dropped from Russell Microcap Value Index
CI
ANI Pharmaceuticals, Inc.(NasdaqGM:ANIP) dropped from Russell 3000E Value Index
CI
ANI Pharmaceuticals to Acquire Alimera Sciences for $381 Million M&A Deal
AQ
HC Wainwright Adjusts ANI Pharmaceuticals Price Target to $94 From $87, Maintains Buy Rating
MT
ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner
AQ
Top Midday Gainers
MT
Sector Update: Health Care Stocks Advance Premarket Monday
MT
Sector Update: Health Care
MT
US Equity Futures Mixed in Premarket Action as Traders Eye Friday's Inflation Data
MT
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Amid Uncertainty Ahead of Key Inflation Data
MT
Transcript : Alimera Sciences, Inc., ANI Pharmaceuticals, Inc. - M&A Call
Top Premarket Gainers
MT
ANI Pharmaceuticals : to Discuss Acquisition of Alimera Sciences Presentation
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANIP Stock
  4. Stock
  5. News Biosante Pharmaceuticals Inc